COO vs ELV
Cooper Companies (The) vs Elevance Health — AI-powered side-by-side comparison
COO
Cooper Companies (The)
71
Buy
VS
ELV
Elevance Health
69
Buy
| Metric | COO | ELV |
|---|
| AI Score |
71
|
69
|
| Price |
$76.13
|
$400.25
|
| P/E Ratio |
64.55×
|
17.79×
|
| ROE |
4.6%
|
12.9%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
64.4%
|
39.0%
|
| Debt / Equity |
0.30×
|
0.69×
|
| Dividend Yield |
0.0%
|
1.7%
|
| RSI (14) |
65.0
|
62.8
|
| Beta |
0.823
|
0.692
|
| Expected Upside |
+1.2%
|
+0.5%
|
AI Committee View
Current Innellis committee reasoning for COO versus ELV.
COO leads by 2 points.
COO scores 71/100 (Buy) versus ELV at 69/100 (Buy).
COO Committee View
100% agreement
4 analysts
The primary driver is 4 consecutive earnings beats -- consistent execution. The main limiting factor is sector concentration is already high (hhi 2971.31). The committee is constructive but not yet at full conviction.
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
- Bearish candlestick pattern(s) detected: Shooting Star.
ELV Committee View
80% agreement
5 analysts
The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is growth rate is decelerating quarter over quarter -- the trend line matters more than the level. The committee is constructive but not yet at full conviction.
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth